Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

682 evidences · page 14 / 28

0,53 correlation_coefficientHopelessness had a modest positive correlation with depression (r = 0.530, P < 0.001) among clinically stable Nigerian adults with sickle cell disease.

Nigeriadrépanocytosepublié 2020Nigerian journal of clinical practicePubMeddocument de 8 observations

1 %The previously reported national prevalence range of sickle cell disease (SCD) in Nigeria was 1% to 3%.

Nigeriadrépanocytosepublié 2025West African journal of medicinePubMeddocument de 8 observations

55 %Seventeen out of 31 tertiary hospitals (55%) offered chronic transfusion therapy (CTT) by top-up or manual exchange transfusion.

Nigeriadrépanocytoseobservé 2014publié 2016International healtheurope_pmcdocument de 11 observations

100 %For HbAC phenotype, isoelectric focusing showed a negative predictive value (NPV) of 100%.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 23 observations

33,3 %Among survivors, approximately one-third had residual neurological deficits.

Nigeriadrépanocytoseobservé March 2022 and February 2025PubMeddocument de 8 observations

Stroke history was less frequent in the Ibadan patients aged ≥18 years.

NigeriaAVC · drépanocytosepublié 2014Hemoglobineurope_pmcdocument de 5 observations

75 %About 75% of annual affected babies with sickle cell disease worldwide are born in sub-Saharan African countries.

Nigeriadrépanocytosepublié 2018Cureuseurope_pmcdocument de 3 observations

66 %The most reported complication of sickle cell disease requiring hospital management is pain crises, ranging from 66% to 96%.

Nigeriadrépanocytose · pain crisespublié 2025Communications medicineeurope_pmcdocument de 4 observations

16,8 x10⁹/LWhite blood cell count in crisis state subjects was 16.8 ± 3.4.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

12,09 cmSickle cell anemia subjects had a larger mean hepatic size than non-SCA subjects (12.09 cm ± 2.23 vs. 11.67 cm ± 1.96).

Nigeriadrépanocytosepublié 2023Nigerian journal of clinical practicePubMeddocument de 9 observations

48 %48% of the interviewed students had bad control practices regarding sickle cell disease.

Nigeriadrépanocytosepublié 2021The Pan African medical journalPubMeddocument de 7 observations

38,4 %The prevalence of myocardial ischemia measuring both cardiac troponin T and electrocardiography in children with sickle cell anemia during vaso-occlusive crisis was 38.4%.

Nigeriadrépanocytose · myocardial ischemiaobservé 2019publié 2024Journal of tropical pediatricsPubMeddocument de 6 observations

3 190 childrenOver a 6-month enrollment period, 3190 children aged from 5 to 12 years with sickle cell anemia were evaluated for eligibility.

Nigeriadrépanocytosepublié 2023Blood advancesPubMeddocument de 6 observations

9 %Paralysis occurred in 9.0% of the 133 children with sickle cell disease.

Nigeriadrépanocytose · paralysisobservé March 2022 and February 2025PubMeddocument de 8 observations

75 %75% of annual global births with sickle cell disease occur in Africa.

Nigeriadrépanocytosepublié 2024BMJ openeurope_pmcdocument de 2 observations

400 000 births_per_yearRoughly 400,000 babies are born with sickle cell disease each year worldwide.

Nigeriadrépanocytosepublié 2024PloS oneeurope_pmcdocument de 3 observations

0,6 %0.6% of mild-to-severe anaemia among children aged 6–59 months in Nigeria was attributable to sickle cell disease.

Nigeriaanémie · drépanocytoseobservé 2018publié 2022BMJ openeurope_pmcdocument de 6 observationsDOI 10.1136/bmjopen-2022-063369

10,6 %10.6% of the SCA patients had severe disease.

Nigeriadrépanocytosepublié 2023Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 12 observations

5 patients5 had pulmonary hypertension.

Nigeriadrépanocytosepublié 2021Hematology (Amsterdam, Netherlands)PubMeddocument de 16 observations

2,733 mmol/lThe SCA group had significantly lowered calcium levels (2.733 ± 1.593 mmol/l) compared to the HBAA control group (1.846 ± 1.123 mmol/l) with p=0.009.

Nigeriadrépanocytoseobservé 2020-12-02 to 2021-03-31publié 2022The Pan African medical journalPubMeddocument de 4 observations

92,5 %347 (92.5%) of the participants had fewer pain crises while using hydroxyurea.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 10 observations

25 %Among 164 mothers of children with SCD in a southwestern state of Nigeria, 42 (25%) were aware of prenatal SCD diagnosis.

Nigeriadrépanocytosepublié 2020TheScientificWorldJournalPubMeddocument de 9 observations

1,6 %1.6 percent of 181 Nigerian subjects had the beta S gene linked to the Hpa-I 7.6 kb fragment.

Nigeriadrépanocytosepublié 1989Tropical and geographical medicineeurope_pmcdocument de 4 observations

Right atrial area was the only significant determinant of relative systemic hypertension in patients with sickle cell anaemia.

Nigeriadrépanocytose · relative systemic hypertensionpublié 2020Indian heart journalPubMeddocument de 3 observations

84,3 %CYP2C19 *1 allele frequency was 84.3% in Nigerian patients with sickle-cell disease.

Nigeriadrépanocytose · paludismepublié 2010Journal of clinical pharmacy and therapeuticseurope_pmcdocument de 10 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.